Russian Cancer Vaccine Ready to Be LaunchedThree leading Russian research institutes have submitted documents to the Ministry of Health to launch production of the country’s first personalized vaccines against melanoma. Scientists are ready to begin patient treatment within one and a half months, Gamaleya Center director Alexander Gintsburg announced at a Russian Historical Society roundtable, according to TASS. In June, Chief Oncologist of the Ministry of Health Andrey Kaprin reported that Russian specialists had begun clinical trials of another cancer vaccine, "Enteromix," involving 48 volunteers. Future Applications and International ComparisonsThe vaccines were developed collaboratively by the Gamaleya Center, Herzen Institute, and Blokhin National Medical Center. Patients with non-small cell cancer will form a second group and receive a separate personalized vaccine that suppresses tumor progression and metastasis formation.